AMENDED AND RESTATED PATENT LICENSE AGREEMENT AGREEMENT No. PM 2202501Patent License Agreement • May 11th, 2022 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
This Amended and Restated Patent License Agreement (the “Patent License Agreement”) is made and entered into as of April 20, 2022 (“Amendment Effective Date”) by and between TFF Pharmaceuticals, Inc. (“Licensee”) and The University of Texas at Austin, on behalf of the Board of Regents of the University of Texas System (“Licensor”), an agency of the State of Texas (collectively referred to as “Parties” or separately as “Party”).
